Alho, Hannu

Mesolimbic dopamine release is linked to symptom severity in pathological gambling

Joutsa, J., Johansson, J., Niemelä, S., Ollikainen, A., Hirvonen, M. M., Piepponen, P., Arponen, E., Alho, H., Voon, V., Rinne, J. O., et al. (2012) · NeuroImage

Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior

Cited by 209

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 141

Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice

Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 140

Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium

Tolonen, J., Rossinen, J., Alho, H., & Harjola, V.-P. (2013) · European Journal of Emergency Medicine

Anesthesia and Sedative AgentsAlcoholism and Thiamine Deficiency

Cited by 45

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice

Kakko, J., Gedeon, C., Sandell, M., Grelz, H., Birkemose, I., Clausen, T., Rúnarsdóttir, V., Simojoki, K., Littlewood, R., Alho, H., et al. (2018) · Substance Abuse Treatment Prevention and Policy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 10